Researchers is significantly advanced its progress of the novel solution for ATTR-CM, employing the compound. Initial patient information reveals significant improvements for patients suffering from a debilitating condition. The emphasis represents BridgeBio's dedication to treating critical medical requirements in the heart disease arena. Attruby